Contact us by submitting a message at the contact form.
Insights
-
Embracing the Lab of the Future: Transforming Biopharma Through Digital Innovation
- March 18, 2024
- Posted by: Zaylan Associates
- Category: Insights
No Comments
Over the next 5-10 years, the biopharma industry is poised to invest hundreds of millions of dollars in “Lab of the Future” (LoF) or “Digital Labs” initiatives, with digital spending expected to surge from $4 billion to $10 billion.
-
Single cell genomics – Invaluable insights into studying heterogeneity, signaling, and stochastic gene expression; Market Overview
- March 18, 2024
- Posted by: Zaylan Associates
- Category: Insights
Single Cell Genomics is one of the most attractive high growth segments of life sciences research. Since the dawn of genomics, samples have been analyzed in bulk,
-
What is Next In Proteomics: Parsing 20 Years of Public Data by AI Maps Trends in Proteomics and Forecasts Technology
- December 14, 2023
- Posted by: admin
- Category: Insights
The trends of the last 20 years in biotechnology were revealed using Consilience’s artificial intelligence and natural language processing (NLP) of publicly available data.
-
Zaylan releases its latest thinking on Proteomics leveraging Consilience.ai engine
- December 12, 2023
- Posted by: admin
- Category: Insights
There is tremendous scientific and technological potential in the field of Proteomics. Human diseases involve proteins, yet our current level of understanding of the proteome is incomplete…
-
Fundamental Shifts In Business Models Are Looming For The Biopharma Sector That Will Determine The Next Generation Of Winners And Losers
- November 30, 2023
- Posted by: admin
- Categories: Insights, Press Releases
The biopharma industry will look very different in the next several years. While biopharma players will still continue to produce and market drugs, their fundamental business models, value proposition, how they organize themselves and go to market will change dramatically.
-
Liquid Biopsy Redefines Disease Diagnosis and Treatment
- January 1, 2019
- Posted by: Zaylan Associates
- Category: Insights
Liquid biopsy is one of the most exciting new developments in life sciences. In cancer and in the area of NIPT (non-invasive prenatal testing), one significant limitation was gaining access to appropriate tissue biopsy from patient in order to perform pathological testing.